Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metastatic CDK12-Mutated Neuroendocrine Tumor of Lung Showed an Exceptional Response to Olaparib and Paclitaxel.

JCO precision oncology - 1 Nov 2021

Bae William Han, Hwang Jin Young, Hur Won Kyung, Choi Jaeyoun, Nam Myungwoo, Choi Yoonhee, Kim Leeseul, Kim Eugene, Fridland Stanislav, Cho Heayoon Shauna, Low Christmann, Yu Emma, Jung Chan Mi, Vagia Elena, Kiedrowski Lesli, Chae Young Kwang

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cyclin-Dependent Kinases
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroendocrine Tumors

Share to Paclitaxel

Share to Phthalazines

Share to Piperazines

Share to Treatment Outcome

Source

Identifiers

PMID: 34994611
DOI: 10.1200/PO.20.00400

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metastatic CDK12-Mutated Neuroendocrine Tumor of Lung Showed an Exceptional Response to Olaparib and Paclitaxel.PMID 34994611Read ↗

Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.Semantic proximity Read ↗

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.Semantic proximity Read ↗

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.Semantic proximity Read ↗

BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.Semantic proximity Read ↗

Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report.Semantic proximity Read ↗

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line TherapySemantic proximity Read ↗

Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?Semantic proximity Read ↗

[Primary large cell neuroendocrine carcinoma of pulmonary artery: a case report and literature review].Semantic proximity Read ↗

Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.Semantic proximity Read ↗

Exceptional Response to Olaparib: A Case Report of Metastatic Esophageal Squamous Cell Carcinoma in a Patient With Fanconi Anemia, Germline FANCA Mutation, and Somatic BRCA2 Mutations.Semantic proximity Read ↗

BRAF V600E-mutated combined large cell neuroendocrine carcinoma and adenocarcinoma responding to targeted therapy.Semantic proximity Read ↗

Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.